In addiction, HG showed significant Survivin over-expression compared to LG non-invasive tumors, sustaining the role that Survivin could play, not only as a predictive biomarker for BC progression [20], but also as a potential therapeutic target. The gene discussed is BIRC5; the disease is breast cancer.